Literature DB >> 1884465

Clinical trials of restenosis after coronary angioplasty.

J J Popma, R M Califf, E J Topol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884465     DOI: 10.1161/01.cir.84.3.1426

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  25 in total

1.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.

Authors:  P W Serruys; D P Foley; P J de Feyter
Journal:  Br Heart J       Date:  1992-10

3.  Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty.

Authors:  J J Ferguson; J T Willerson
Journal:  Tex Heart Inst J       Date:  1992

Review 4.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Short-term exercise training prevents micro- and macrovascular disease following coronary stenting.

Authors:  Xin Long; Ian N Bratz; Mouhamad Alloosh; Jason M Edwards; Michael Sturek
Journal:  J Appl Physiol (1985)       Date:  2010-03-18

6.  Molecular atherectomy for restenosis.

Authors:  W Casscells; D A Lappi; A Baird
Journal:  Trends Cardiovasc Med       Date:  1993 Nov-Dec       Impact factor: 6.677

Review 7.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

8.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 9.  Pathology of atherosclerosis and stenting.

Authors:  Frank D Kolodgie; Gaku Nakazawa; Giuseppe Sangiorgi; Elena Ladich; Allen P Burke; Renu Virmani
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

10.  Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.

Authors:  E H Ohlstein; S A Douglas; C P Sung; T L Yue; C Louden; A Arleth; G Poste; R R Ruffolo; G Z Feuerstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.